Verisign Inc (VRSN) 89.25 $VRSN Uptrend Call Working As

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Verisign Inc (VRSN) 89.25 $VRSN

Uptrend Call Working As VeriSign Stock Rises 11.8% (VRSN)
Comtex SmarTrend(R) - Wed Mar 02, 12:13PM CST
SmarTrend identified an Uptrend for VeriSign (NASDAQ:VRSN) on February 16th, 2016 at $78.75. In approximately 2 weeks, VeriSign has returned 11.81% as of today's recent price of $88.05.
VRSN: 89.25 (+0.36)

Downtrend Call Working As VeriSign Stock Falls 15.5% (VRSN)
Comtex SmarTrend(R) - Wed Feb 10, 6:06PM CST
SmarTrend identified a Downtrend for VeriSign (NASDAQ:VRSN) on December 18th, 2015 at $87.34. In approximately 2 months, VeriSign has returned 15.51% as of today's recent price of $73.79.
VRSN: 89.25 (+0.36)

What's in the Cards for VeriSign (VRSN) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 1:00PM CST
VeriSign, Inc. (VRSN) is set to report fourth-quarter and full-year 2015 results on Feb 11.
VRSN: 89.25 (+0.36), SHOP: 26.99 (+0.79), NTES: 144.48 (-1.28), JNPR: 25.36 (-0.28)

14.5% Return Seen to Date on SmarTrend VeriSign Call (VRSN)
Comtex SmarTrend(R) - Tue Feb 02, 5:22PM CST
SmarTrend identified a Downtrend for VeriSign (NASDAQ:VRSN) on December 18th, 2015 at $87.34. In approximately 2 months, VeriSign has returned 14.52% as of today's recent price of $74.65.
VRSN: 89.25 (+0.36)

Why Warren Buffett is Right About These Two Mid-Cap Stocks
at The Street - Sat Jan 09, 2:45PM CST
The Oracle of Omaha recently made major bets on two growth stocks that don't pay dividends. What does Buffett know that most income-oriented investors don't?
VRSN: 89.25 (+0.36), USG: 23.27 (-0.41), BRK.A: 210,530.00 (-840.00)

VeriSign Set to Possibly Rebound After Yesterday's Selloff of 3.03%
Comtex SmarTrend(R) - Tue Jan 05, 4:26PM CST
VeriSign (NASDAQ:VRSN) traded in a range yesterday that spanned from a low of $80.58 to a high of $83.91. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $82.44 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRSN: 89.25 (+0.36)

VeriSign (VRSN) Stock Price Target Upped at Credit Suisse
at The Street - Tue Jan 05, 2:59PM CST
Credit Suisse increased its price target on VeriSign (VRSN) stock to $55 from $50 on Tuesday.
VRSN: 89.25 (+0.36)

Stock Futures Reverse, Mixed; Smith & Wesson, First Solar Surge
at Investor's Business Daily - Tue Jan 05, 8:15AM CST
Stock futures were mixed Tuesday, but had improved sharply a half-hour ahead of the start of regular trade. Dow futures traded down 12.9 points, up from a 98-point loss an hour earlier. S&P 500 and Nasdaq 100 futures had reversed and climbed into...
VRSN: 89.25 (+0.36), FSLR: 68.46 (+0.23), HA: 46.28 (-0.42), RGR: 69.75 (-6.53), SWHC: 26.52 (-2.53)

Verisign to Report Fourth Quarter and Full Year 2015 Financial Results
Marketwired - Mon Jan 04, 3:05PM CST
VeriSign, Inc. (NASDAQ: VRSN), a global leader in domain names and Internet security, announced that its earnings call for the fourth quarter and full year 2015 will take place on Thursday, Feb. 11, 2016, at 4:30 p.m. (EST). The earnings news release will be distributed to the wire services at approximately 4:05 p.m. that day and will also be available directly from the company's website at https://investor.verisign.com.
VRSN: 89.25 (+0.36)

The 10 Best-Performing Stocks in the S&P 500 in 2015
at The Street - Thu Dec 31, 3:50PM CST
The S&P 500 Index finished 2015 down slightly for the year, but these 10 stocks had outstanding performance.
NFLX: 98.36 (-1.23), VRSN: 89.25 (+0.36), AMZN: 582.95 (+13.32), ATVI: 32.21 (-0.37), TSS: 45.98 (-0.22), FSLR: 68.46 (+0.23), GOOGL: 754.84 (-2.72), HRL: 43.27 (-0.42), GOOG: 735.30 (-2.76), CVC: 32.96 (-0.02), NVDA: 34.48 (+0.05)

Qihoo (QIHU) Finally Goes Private in $9.3 Billion Deal
Zacks Equity Research - Zacks Investment Research - Mon Dec 21, 3:33PM CST
Putting speculations to rest, Qihoo 360 Technology Co. Ltd. (QIHU) is officially being taken private by a group of investors headed by the company's CEO Zhou Hongyi, without altering any terms of the offer made in June.
VRSN: 89.25 (+0.36), QIHU: 75.24 (+0.24), ELLI: 83.93 (+1.98), ACTA: 8.79 (+0.09)

Watch for VeriSign to Potentially Rebound After Falling 2.40% Yesterday
Comtex SmarTrend(R) - Thu Dec 17, 4:50PM CST
VeriSign (NASDAQ:VRSN) traded in a range yesterday that spanned from a low of $87.64 to a high of $90.59. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $88.00 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRSN: 89.25 (+0.36)

SmarTrend Watching for Potential Rebound in Shares of VeriSign After 2.40% Loss
Comtex SmarTrend(R) - Thu Dec 17, 4:49PM CST
VeriSign (NASDAQ:VRSN) traded in a range yesterday that spanned from a low of $87.64 to a high of $90.59. Yesterday, the shares fell 2.4%, which took the trading range below the 3-day low of $88.00 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRSN: 89.25 (+0.36)

Internet Grows to 299 Million Domain Names in the Third Quarter of 2015
Marketwired - Thu Dec 17, 3:23PM CST
VeriSign, Inc. (NASDAQ: VRSN), a global leader in domain names and Internet security, today announced that approximately 3.1 million domain names were added to the Internet in the third quarter of 2015, bringing the total number of registered domain names to approximately 299 million worldwide across all top-level domains (TLDs) as of Sept. 30, 2015, according to the latest Domain Name Industry Brief.
VRSN: 89.25 (+0.36)

27.0% Return Seen to Date on SmarTrend VeriSign Call (VRSN)
Comtex SmarTrend(R) - Tue Dec 15, 10:24AM CST
SmarTrend identified an Uptrend for VeriSign (NASDAQ:VRSN) on September 16th, 2015 at $70.37. In approximately 3 months, VeriSign has returned 27.01% as of today's recent price of $89.37.
VRSN: 89.25 (+0.36)

VeriSign Has Returned 27.0% Since SmarTrend Recommendation (VRSN)
Comtex SmarTrend(R) - Tue Dec 15, 10:09AM CST
SmarTrend identified an Uptrend for VeriSign (NASDAQ:VRSN) on September 16th, 2015 at $70.37. In approximately 3 months, VeriSign has returned 27.01% as of today's recent price of $89.37.
VRSN: 89.25 (+0.36)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI-Driven Software Growth Faces Profitability Hurdles

Updated Category News Views 153

AI and Growth: A Tale of Two Strategies Is AI the superhero we’ve been waiting for, or just another fad? The KeyBanc Capital Markets' 2026 AI x Software Benchmark throws more questions into the ring than it answers. This benchmark isn't just numbers on a page; it's a pulse check on how AI is reshaping the software landscape. Seeing AI-native firms grow at a dizzying 34%...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Dana Concludes Tender Offers for Senior Notes

Updated Category News Views 130

An Investor's Glance at Dana's Strategic Moves Dana Incorporated (NYSE: DAN) just pulled a bold move with their tender offers, snapping up a hefty $357,873,000 in outstanding principal on their senior notes. This isn’t just pocket change; folks holding out for securities can feel the tension of watching big numbers get shuffled around. You gotta wonder, what's the play...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 98

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
Euroandinos Paita Closes Consent for 2037 Notes

Updated Category News Views 122

Port Strategy and Financial Implications Terminales Portuarios Euroandinos Paita S.A., nestled in the Peruvian transport sector, has been tight-rope walking through its debt landscape. Announcing a successful consent solicitation on November 13, 2026, they've taken a significant step towards reconfiguring their long-term financing game. This puppet show of paperwork...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 227

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 148

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 73

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 85

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 126

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming a Small Investment in Royal Caribbean Into Wealth

Updated Category News Views 156

The Power of Long-Term Investing in Royal Caribbean Investing in the stock market can often seem intimidating, especially for newcomers. However, a closer look at companies like Royal Caribbean Gr (NASDAQ: RCL) demonstrates the potential rewards of disciplined investing over time. Having shown remarkable performance, Royal Caribbean has an annualized return that exceeds...

Continue Reading
Immuron's Financial Growth and Clinical Progress Update

Updated Category News Views 149

Immuron's Consistent Growth and Exciting Projects Update Immuron Limited, a biopharmaceutical company based in Australia and publicly traded on the NASDAQ under the ticker IMRN and ASX ticker IMC.AX, is announcing some significant updates that reflect its ongoing commitment to healthcare innovation. The company's recent sales figures and progress in clinical trials...

Continue Reading
General Motors Growth Potential: Insights from Analysts

Updated Category News Views 281

General Motors Gets a Boost from Analysts In recent developments, General Motors Company (NYSE: GM) has garnered notable attention from financial analysts, particularly following Barclays' upgrade of the stock. The analysts play a vital role in assessing the market potential for stocks, and their insights can greatly influence investor confidence. Analyst Upgrades Impact...

Continue Reading
BioAge Labs Faces Class Action Lawsuit: Deadline Approaches Soon

Updated Category News Views 314

BioAge Labs Faces Class Action Lawsuit Investors of BioAge Labs, Inc. (NASDAQ: BIOA) are currently navigating a challenging landscape as a class action lawsuit is underway against the biopharmaceutical company. This underscores the importance for shareholders to stay informed about the developments following the company's recent stock performance and ensuing legal...

Continue Reading
Audit BEE Celebrates Dual Honors at Global Brand Awards

Updated Category News Views 177

Audit BEE Wins Prestigious Global Brand Awards Audit BEE has achieved remarkable recognition for its Excellence in Compliance and Advisory Leadership, recently celebrated at the prestigious Global Brand Awards. These awards, organized by Global Brands Magazine, acknowledge outstanding contributions from brands worldwide, showing the importance of excellence across various...

Continue Reading